Marco Prado is a Canada Research Chair in Neurochemistry of Dementia with strong interest in understanding how molecular and cellular changes in neurodegenerative diseases contribute to protein misfolding and cognitive failure. Marco Prado serves in multiple advisory boards, including the Institute Advisory Board for the Institute of Neuroscience Mental Health and Addiction (CIHR-INMHA, 2018-) and the leadership of BrainsCAN (Western's $66M CFREF), as a Co-Chair of Internal Funding. He is the current Deputy Chief Editors for Reviews for the Journal of eurochemistry, the premier scholar publication in brain chemistry. In recognition for his research, Marco Prado received the prestigious Guggenheim Fellowship (Guggenheim Foundation), a Faculty Scholar Award (University of Western
Ontario), the Dean's Research Excellence Award (University of Western Ontario) and a visiting faculty award from the Brazilian Government. His laboratory has been funded consistently in the last 24 years by government and private agencies in three different countries (Brazil, USA and Canada). He has published over 160 peer-reviewed manuscripts and he is currently spearheading an Open Science Repository for high-level cognitive data obtained with mouse models of neurodegenerative diseases. This effort will support a community of more than 300 laboratories to increase reproducibility and replicability of cognitive datasets in pre-clinical research.